What is the pipeline for future medications for obesity?

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality. Our better understanding of the weight regulation mechanisms and the role of gut-brain axis on appetite has led to the development of safe and effective entero-pancreatic hormone-based treatme...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of obesity (2005) Jg. 49; H. 3; S. 433
Hauptverfasser:	Melson, Eka, Ashraf, Uzma, Papamargaritis, Dimitris, Davies, Melanie J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.03.2025
Schlagworte:	Anti-Obesity Agents - therapeutic use Glucagon-Like Peptide 1 Glucagon-Like Peptide-1 Receptor Agonists Glucagon-Like Peptides - therapeutic use Humans Obesity - drug therapy
ISSN:	1476-5497, 1476-5497
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!